nQ Medical's artificial intelligence technology has shown in four years of clinical trials at MIT to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders. nQ focuses on the analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders.

Biotechnology

nQ Medical

R. A. Bavasso

Mark Pascarella

Gary Johnson

Levi A.

Teresa Arroyo Gallego

Kevin Forness

Rahul Mahajan

Sri Mruthik

Advisory Team

Leadership Team

Engineering Team

Teams at nQ Medical

Advisory Team

Leadership Team

Engineering Team